Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions — Stella

Home/Juvenile Idiopathic Arthritis/

View on ClinicalTrials.gov

Recruiting

Back to Juvenile Idiopathic Arthritis trials

Trial locations(1 site)

United States

Children's National Health System, Washington D.C., District of Columbia

Key details

Sponsor

Children's National Research Institute

Enrollment target

~90 participants

Started

July 2021

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

5 Years – 21 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.